Latest filing published 06 Jul 2016 for Abbott Laboratories.
Insider track record
Jean-Yves Pavee: trading record in brief
Jean-Yves Pavee is a declared insider of Abbott Laboratories, with filings sourced from SEC (Form 4). The record holds 33 filings, for trades running from 6 December 2013 to 1 July 2016.
No open-market purchase appears, only 7 sales worth €752k. Besides market trades, the filings include 15 share grants and 3 option exercises. So far in 2016, the count stands at no purchases and 2 sales.
The latest filing, published on 6 July 2016, reports a share grant in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jean-Yves Pavee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,077 shares0Common shares without par valueSEC:0001179110-16-027477:0
- 2,431 shares@ US$39.3134.9% of flowCommon shares without par valueSEC:0001179110-16-027477:1
- 2,934 shares0Common shares without par valueSEC:0001179110-16-026632:0
- 1,467 shares0Common shares without par valueSEC:0001179110-16-026632:1
- 1,467 shares0Common shares without par valueSEC:0001179110-16-026632:2
- 11,394 shares0Common shares without par valueSEC:0001179110-16-020664:0
- 2,280 shares@ US$39.5233.4% of flowCommon shares without par valueSEC:0001179110-16-020664:1
- 1,665 shares@ US$39.2424.3% of flowCommon shares without par valueSEC:0001179110-16-020664:2
- 318 shares@ US$37.134.3% of flowCommon shares without par valueSEC:0001179110-16-019504:0
- 233 shares@ US$37.133.1% of flowCommon shares without par valueSEC:0001179110-16-019504:1
- 6,076 shares0Common shares without par valueSEC:0001179110-15-010823:0
- 2,431 shares@ US$49.08Common shares without par valueSEC:0001179110-15-010823:1
- 5,200 shares@ US$25.25Common shares without par valueSEC:0001179110-15-009279:0
- 5,300 shares@ US$26.70Common shares without par valueSEC:0001179110-15-009279:1
- 10,500 shares@ US$49.00Common shares without par valueSEC:0001179110-15-009279:2
- 4,462 shares0Common shares without par valueSEC:0001179110-15-004029:0
- 1,116 shares@ US$47.61Common shares without par valueSEC:0001179110-15-004029:1
- 652 shares@ US$47.48Common shares without par valueSEC:0001179110-15-004029:2
- 2,966 shares0Common shares without par valueSEC:0001179110-15-002848:0
- 1,001 shares@ US$46.09Common shares without par valueSEC:0001179110-15-002848:1
- 283 shares@ US$46.09Common shares without par valueSEC:0001179110-15-002848:2
- 621 shares@ US$46.41Common shares without par valueSEC:0001179110-15-002848:3
- 2,966 shares0Common shares without par valueSEC:0001179110-15-002848:4
- 5,933 shares0Common shares without par valueSEC:0001179110-14-018570:0
- 2,967 shares0Common shares without par valueSEC:0001179110-14-018570:1
25 of 33 declarations
